They found the fat mass declined, waist circumference declined, strength remained the same, and the percentage of fat-free mass improved.
I can find no study supporting the claim by podcasters, bloggers, and internet experts that support the claim that semaglutide has an unfavorable effect on lean body mass as a percentage of total body weight.
Semaglutide is the name for a peptide found in diabetic and weight loss medications.First developed for managing blood sugar in patients with type II diabetes, it has gained popularity for it’s remarkable ability for individuals to lose weight.
The hype around the newest FDA-approved weight loss injections is well-founded. At first, I was very skeptical, and about a year ago, I wrote a blog about the drug semaglutide (branded as Wegovy® for weight loss in the US) and it's massive cost.
As reported in March of 2021, semaglutide, a diabetes weekly shot, helped nondiabetic overweight and obese adults lose a remarkable amount of weight over a period of 68 weeks. There were two groups of people, placebo users, and active drug (semaglutide) users. Neither group knew what they were injecting weekly to remove the "placebo effect".
Wegovy is the newest FDA approved weight loss shot that hit the market in Summer of 2021 that has the most weight loss results than any of its kind. In this blog, Dr. Charles Mok discussed the pros and cons of this weight loss drug and compares it to others on the market.